LTHUQ yields 20000000.00% · PFE yields 6.13%● Live data
📍 LTHUQ pulled ahead of the other in Year 1
Combined, LTHUQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LTHUQ + PFE for your $10,000?
Lithium Technology Corporation engages in the design, manufacture, marketing, and delivery of rechargeable energy storage solutions. The company designs and builds large format cylindrical lithium-ion (Li-ion) rechargeable cells, as well as Li-ion rechargeable batteries with battery management systems for use in transportation, military/national security, and stationary power markets. Its product portfolio includes large format high power cells ranging from 7.5 to 45 Ah with high discharge capabilities designed for HEV and military applications; high energy cells ranging from 10 to 485 Ah for various applications, such as back-up power and remote standby installations; large batteries up to 600V and capacity of more than 1.2 MWh; and standard cells that are assembled into custom large batteries complete with electronics to manage the batteries. The company markets its products to industrial, retail, and government customers, as well as to scientific research facilities and national defense agencies primarily in the United States, United Kingdom, and Germany. Lithium Technology Corporation is headquartered in Fairfax, Virginia. On December 5, 2014, Lithium Technology Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Virginia.On June 12, 2015, the voluntary petition of Lithium Technology Corp. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on December 5, 2014.
Full LTHUQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.